AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2017
Jan 17, 2017
34705_dirs_2017-01-17_3d57b886-b5ce-4ca7-80ac-f9a652a9157a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2017-01-13
Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-13 | Common stock | D | 34400 | $0.383 | Disposed | 197889 | Indirect |
| 2017-01-13 | Common stock | D | 14400 | $0.370 | Disposed | 183889 | Indirect |
| 2017-01-13 | Common stock | D | 1600 | $0.400 | Disposed | 182289 | Indirect |
| 2017-01-13 | Common stock | A | 330000 | $0.000 | Acquired | 512289 | Indirect |
| 2017-01-13 | Common stock | A | 807433 | $0.000 | Acquired | 1426950 | Direct |
Footnotes
F1: Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.
F2: Represents shares held directly by Parveen Mukunda.
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15